Bio-Rad Laboratories Pre-Tax Profit Margin 2012-2026 | BIO
Current and historical pre-tax profit margin for Bio-Rad Laboratories (BIO) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bio-Rad Laboratories pre-tax profit margin for the three months ending June 30, 2026 was .
| Bio-Rad Laboratories Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $2.59B | $0.35B | 13.52% |
| 2026-03-31 | $2.59B | $0.22B | 8.57% |
| 2025-12-31 | $2.58B | $1.00B | 38.52% |
| 2025-09-30 | $2.56B | $-0.84B | -32.96% |
| 2025-06-30 | $2.56B | $0.45B | 17.61% |
| 2025-03-31 | $2.54B | $-2.75B | -108.18% |
| 2024-12-31 | $2.57B | $-2.34B | -91.20% |
| 2024-09-30 | $2.58B | $-1.01B | -38.94% |
| 2024-06-30 | $2.56B | $-1.73B | -67.50% |
| 2024-03-31 | $2.61B | $-0.44B | -17.04% |
| 2023-12-31 | $2.67B | $-0.85B | -31.82% |
| 2023-09-30 | $2.72B | $-0.19B | -6.88% |
| 2023-06-30 | $2.77B | $-0.53B | -19.18% |
| 2023-03-31 | $2.78B | $-0.25B | -9.03% |
| 2022-12-31 | $2.80B | $-4.70B | -167.88% |
| 2022-09-30 | $2.81B | $-7.82B | -278.86% |
| 2022-06-30 | $2.87B | $-2.59B | -90.32% |
| 2022-03-31 | $2.90B | $-0.22B | -7.46% |
| 2021-12-31 | $2.92B | $5.45B | 186.42% |
| 2021-09-30 | $2.98B | $8.57B | 287.42% |
| 2021-06-30 | $2.88B | $5.23B | 181.49% |
| 2021-03-31 | $2.70B | $5.32B | 196.82% |
| 2020-12-31 | $2.55B | $4.92B | 193.17% |
| 2020-09-30 | $2.38B | $4.53B | 190.25% |
| 2020-06-30 | $2.29B | $2.51B | 109.37% |
| 2020-03-31 | $2.33B | $2.03B | 87.25% |
| 2019-12-31 | $2.31B | $2.26B | 97.79% |
| 2019-09-30 | $2.31B | $0.52B | 22.60% |
| 2019-06-30 | $2.29B | $1.21B | 52.69% |
| 2019-03-31 | $2.29B | $0.78B | 33.86% |
| 2018-12-31 | $2.29B | $0.51B | 22.40% |
| 2018-09-30 | $2.29B | $1.60B | 69.75% |
| 2018-06-30 | $2.28B | $1.28B | 56.11% |
| 2018-03-31 | $2.21B | $0.94B | 42.59% |
| 2017-12-31 | $2.16B | $0.10B | 4.54% |
| 2017-09-30 | $2.11B | $0.02B | 1.14% |
| 2017-06-30 | $2.09B | $0.02B | 0.77% |
| 2017-03-31 | $2.10B | $0.04B | 2.00% |
| 2016-12-31 | $2.07B | $0.04B | 2.03% |
| 2016-09-30 | $2.07B | $0.12B | 6.00% |
| 2016-06-30 | $2.03B | $0.13B | 6.21% |
| 2016-03-31 | $2.02B | $0.14B | 6.89% |
| 2015-12-31 | $2.02B | $0.15B | 7.23% |
| 2015-09-30 | $2.05B | $0.14B | 6.74% |
| 2015-06-30 | $2.11B | $0.14B | 6.40% |
| 2015-03-31 | $2.14B | $0.14B | 6.73% |
| 2014-12-31 | $2.18B | $0.13B | 6.07% |
| 2014-09-30 | $2.18B | $0.13B | 6.01% |
| 2014-06-30 | $2.15B | $0.10B | 4.83% |
| 2014-03-31 | $2.14B | $0.10B | 4.86% |
| 2013-12-31 | $2.13B | $0.11B | 5.30% |
| 2013-09-30 | $2.10B | $0.13B | 6.23% |
| 2013-06-30 | $2.10B | $0.19B | 9.10% |
| 2013-03-31 | $2.08B | $0.21B | 9.99% |
| 2012-12-31 | $2.07B | $0.23B | 11.12% |
| 2012-09-30 | $2.05B | $0.25B | 12.27% |
| 2012-06-30 | $2.06B | $0.25B | 12.22% |
| 2012-03-31 | $2.08B | $0.24B | 11.76% |
| 2011-12-31 | $2.07B | $0.25B | 11.86% |
| 2011-09-30 | $2.06B | $0.22B | 10.64% |
| 2011-06-30 | $2.01B | $0.22B | 10.98% |
| 2011-03-31 | $1.96B | $0.22B | 11.13% |
| 2010-12-31 | $1.93B | $0.22B | 11.41% |
| 2010-09-30 | $1.89B | $0.21B | 10.85% |
| 2010-06-30 | $1.88B | $0.20B | 10.54% |
| 2010-03-31 | $1.84B | $0.19B | 10.45% |
| 2009-12-31 | $1.78B | $0.19B | 10.37% |
| 2009-09-30 | $1.74B | $0.15B | 8.46% |
| 2009-06-30 | $1.72B | $0.14B | 8.09% |
| 2009-03-31 | $1.74B | $0.15B | 8.38% |
| 2008-12-31 | $1.76B | $0.14B | 8.05% |
| 2008-09-30 | $1.78B | $0.15B | 8.50% |
| 2008-06-30 | $1.67B | $0.14B | 8.54% |
| 2008-03-31 | $1.56B | $0.12B | 7.88% |
| 2007-12-31 | $1.46B | $0.12B | 8.28% |
| 2007-09-30 | $1.35B | $0.13B | 9.81% |
| 2007-06-30 | $1.31B | $0.13B | 9.85% |
| 2007-03-31 | $1.29B | $0.14B | 10.47% |
| 2006-12-31 | $1.27B | $0.14B | 11.15% |
| 2006-09-30 | $1.24B | $0.13B | 10.26% |
| 2006-06-30 | $1.22B | $0.12B | 9.54% |
| 2006-03-31 | $1.19B | $0.10B | 8.33% |
| 2005-12-31 | $1.18B | $0.09B | 7.88% |
| 2005-09-30 | $1.18B | $0.11B | 9.40% |
| 2005-06-30 | $1.16B | $0.10B | 8.56% |
| 2005-03-31 | $1.13B | $0.10B | 9.14% |
| 2004-12-31 | $1.09B | $0.10B | 8.89% |
| 2004-09-30 | $1.04B | $0.10B | 9.46% |
| 2004-06-30 | $1.02B | $0.10B | 10.21% |
| 2004-03-31 | $1.00B | $0.11B | 10.83% |
| 2003-12-31 | $0.98B | $0.12B | 11.73% |
| 2003-09-30 | $0.94B | $0.11B | 12.00% |
| 2003-06-30 | $0.93B | $0.12B | 13.41% |
| 2003-03-31 | $0.90B | $0.12B | 12.87% |
| 2002-12-31 | $0.87B | $0.11B | 12.14% |
| 2002-09-30 | $0.88B | $0.10B | 11.44% |
| 2002-06-30 | $0.84B | $0.09B | 10.19% |
| 2002-03-31 | $0.82B | $0.08B | 9.59% |
| 2001-12-31 | $0.82B | $0.07B | 7.96% |
| 2001-09-30 | $0.76B | $0.06B | 7.22% |
| 2001-06-30 | $0.75B | $0.07B | 8.64% |
| 2001-03-31 | $0.74B | $0.05B | 7.26% |
| 2000-12-31 | $0.73B | $0.04B | 6.06% |
| 2000-09-30 | $0.74B | $0.02B | 2.16% |
| 2000-06-30 | $0.68B | $0.00B | 0.15% |
| 2000-03-31 | $0.61B | $0.01B | 0.82% |
| 1999-12-31 | $0.55B | $0.02B | 2.91% |
| 1999-09-30 | $0.48B | $0.04B | 8.63% |
| 1999-06-30 | $0.46B | $0.04B | 8.26% |
| 1999-03-31 | $0.45B | $0.04B | 8.19% |
| 1998-12-31 | $0.44B | $0.03B | 7.69% |
| 1998-09-30 | $0.44B | $0.03B | 6.15% |
| 1998-06-30 | $0.44B | $0.03B | 6.38% |
| 1998-03-31 | $0.44B | $0.03B | 5.72% |
| 1997-12-31 | $0.43B | $0.02B | 5.39% |
| 1997-09-30 | $0.43B | $0.03B | 6.12% |
| 1997-06-30 | $0.42B | $0.03B | 7.33% |
| 1997-03-31 | $0.42B | $0.03B | 8.15% |
| 1996-12-31 | $0.42B | $0.04B | 8.83% |
| 1996-09-30 | $0.41B | $0.04B | 9.69% |
| 1996-06-30 | $0.41B | $0.04B | 9.05% |
| 1996-03-31 | $0.41B | $0.04B | 8.85% |
| 1995-12-31 | $0.40B | $0.03B | 8.56% |
| 1995-09-30 | $0.39B | $0.03B | 8.29% |
| 1995-06-30 | $0.38B | $0.03B | 8.22% |
| 1995-03-31 | $0.36B | $0.03B | 7.42% |
| 1994-12-31 | $0.36B | $0.02B | 6.74% |
| 1994-09-30 | $0.35B | $0.02B | 4.91% |
| 1994-06-30 | $0.34B | $0.01B | 3.52% |
| 1994-03-31 | $0.34B | $0.01B | 2.07% |
| 1993-12-31 | $0.33B | $0.00B | 1.22% |
| 1993-09-30 | $0.33B | $0.01B | 2.12% |
| 1993-06-30 | $0.33B | $0.01B | 3.33% |
| 1993-03-31 | $0.33B | $0.03B | 7.93% |
| 1992-12-31 | $0.33B | $0.03B | 8.16% |
| 1992-09-30 | $0.33B | $0.03B | 8.62% |
| 1992-06-30 | $0.32B | $0.03B | 8.41% |
| 1992-03-31 | $0.32B | $0.01B | 4.40% |
| 1991-12-31 | $0.31B | $0.01B | 4.50% |
| 1991-09-30 | $0.31B | $0.02B | 5.18% |
| 1991-06-30 | $0.30B | $0.02B | 5.26% |
| 1991-03-31 | $0.30B | $0.02B | 5.74% |
| 1990-12-31 | $0.29B | $0.02B | 5.92% |
| 1990-09-30 | $0.27B | $0.02B | 5.88% |
| 1990-06-30 | $0.26B | $0.02B | 5.84% |
| 1990-03-31 | $0.25B | $0.02B | 6.45% |
| 1989-12-31 | $0.24B | $0.02B | 6.36% |
| 1989-09-30 | $0.22B | $0.01B | 5.80% |
| 1989-06-30 | $0.22B | $0.01B | 6.51% |
| 1989-03-31 | $0.20B | $0.01B | 6.86% |
| 1988-12-31 | $0.20B | $0.01B | 7.04% |
| 1988-09-30 | $0.19B | $0.01B | 7.37% |
| 1988-06-30 | $0.18B | $0.01B | 7.10% |
| 1988-03-31 | $0.17B | $0.01B | 7.51% |
| 1987-12-31 | $0.16B | $0.01B | 7.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.225B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |